Abstract
Quartile forced vital capacity changes at 3, 6, 9 and 12 months with pirfenidone in patients with Idiopathic Pulmonary Fibrosis: a pooled phase III analysis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have